Table of Contents
1 Introduction 10
1.1 Industry Definition and Research Scope 10
1.1.1 Industry Definition 10
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Industry Research Methodology 14
1.2.2 Industry Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 17
1.2.6 Industry Size/Share Estimation 18
1.2.7 Research Limitations 19
1.3 Executive Summary 20
2 Industry Overview and Dynamics 23
2.1 Industry Size and Forecast 23
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Industry 27
2.2 Major Growth Drivers 29
2.3 Industry Restraints and Challenges 32
2.4 Emerging Opportunities and Industry Trends 35
2.5 Porter's Fiver Forces Analysis 39
3 Segmentation of Global Industry by Formulation 43
3.1 Industry Overview by Formulation 43
3.2 Tablets 45
3.3 Capsules 46
3.4 Injectable 47
3.5 Sprays 48
3.6 Suspensions 49
3.7 Powders 50
3.8 Other Formulations 51
4 Segmentation of Global Industry by Route of Administration 52
4.1 Industry Overview by Route of Administration 52
4.2 Oral Medicine 54
4.3 Topical Medicine 55
4.4 Parenteral Medicine 56
4.5 Inhalations 57
4.6 Other Routes of Administration 58
5 Segmentation of Global Industry by Age Group 59
5.1 Industry Overview by Age Group 59
5.2 Children & Adolescents 61
5.3 Adults 62
5.4 Geriatric 63
6 Segmentation of Global Industry by Therapeutic Application 64
6.1 Industry Overview by Therapeutic Application 64
6.2 Cardiovascular Diseases 66
6.3 Pain 67
6.4 Diabetes 68
6.5 Cancer 69
6.6 Respiratory Diseases 70
6.7 Neurological Diseases 71
6.8 Orthopedics 72
6.9 Other Applications 73
7 Segmentation of Global Industry by Drug Type 74
7.1 Industry Overview by Drug Type 74
7.2 Branded Prescription Drugs 76
7.3 Generic Prescription Drugs 77
7.4 OTC Drugs 78
8 Segmentation of Global Industry by Distribution Channels 79
8.1 Industry Overview by Distribution Channels 79
8.2 Retail Channels 81
8.3 Non-retail Channels 82
9 Segmentation of Global Industry by Manufacturing Facility 83
9.1 Industry Overview by Manufacturing Facility 83
9.2 In-house Facility 85
9.3 Outsourced Facility 86
10 Segmentation of Global Industry by Region 87
10.1 Geographic Industry Overview 2020-2027 87
10.2 North America Industry 2020-2027 by Country 91
10.2.1 Overview of North America Industry 91
10.2.2 U.S. 94
10.2.3 Canada 98
10.2.4 Mexico 100
10.3 European Industry 2020-2027 by Country 102
10.3.1 Overview of European Industry 102
10.3.2 UK 105
10.3.3 France 107
10.3.4 Germany 109
10.3.5 Spain 111
10.3.6 Italy 113
10.3.7 Russia 115
10.3.8 Rest of European Industry 117
10.4 Asia-Pacific Industry 2020-2027 by Country 119
10.4.1 Overview of Asia-Pacific Industry 119
10.4.2 China 122
10.4.3 Japan 124
10.4.4 India 127
10.4.5 Australia 129
10.4.6 South Korea 131
10.4.7 Rest of APAC Region 133
10.5 South America Industry 2020-2027 by Country 135
10.5.1 Argentina 138
10.5.2 Brazil 140
10.5.3 Chile 142
10.5.4 Rest of South America Industry 144
10.6 MEA Industry 2020-2027 by Country 145
10.6.1 UAE 148
10.6.2 Saudi Arabia 150
10.6.3 South Africa 152
10.6.4 Other National Markets 154
11 Competitive Landscape 155
11.1 Overview of Key Vendors 155
11.2 New Product Launch, Partnership, Investment, and M&A 158
11.3 Company Profiles 159
Abbott Laboratories 159
Aenova Group 161
Amgen 162
AstraZeneca 163
Catalent Inc. 164
Eli Lilly and Company 165
F. Hoffmann-La Roche Ltd. 166
Gilead Sciences 167
GlaxoSmithKline plc 168
Johnson & Johnson 169
Lonza Group 170
Lupin 171
Merck & Co., Inc. 172
Novartis AG 173
Novo Nordisk 174
Pfizer, Inc. 175
Roche 176
Sanofi SA 177
Takeda 178
12 Investing in Global Industry: Risk Assessment and Management 179
12.1 Risk Evaluation of Global Industry 179
12.2 Critical Success Factors (CSFs) 182
Related Reports and Products 185